Treace Medical Concepts (TMCI) Competitors $6.54 -0.15 (-2.24%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMCI vs. TNDM, CDRE, EYE, LQDA, AORT, KMTS, BLFS, PLSE, FNA, and MDXGShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include Tandem Diabetes Care (TNDM), Cadre (CDRE), National Vision (EYE), Liquidia (LQDA), Artivion (AORT), Kestra Medical Technologies (KMTS), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Paragon 28 (FNA), and MiMedx Group (MDXG). These companies are all part of the "medical equipment" industry. Treace Medical Concepts vs. Tandem Diabetes Care Cadre National Vision Liquidia Artivion Kestra Medical Technologies BioLife Solutions Pulse Biosciences Paragon 28 MiMedx Group Tandem Diabetes Care (NASDAQ:TNDM) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability. Is TNDM or TMCI more profitable? Tandem Diabetes Care has a net margin of -14.84% compared to Treace Medical Concepts' net margin of -30.33%. Tandem Diabetes Care's return on equity of -44.19% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Tandem Diabetes Care-14.84% -44.19% -11.99% Treace Medical Concepts -30.33%-51.12%-26.36% Do analysts prefer TNDM or TMCI? Tandem Diabetes Care presently has a consensus target price of $39.81, indicating a potential upside of 76.49%. Treace Medical Concepts has a consensus target price of $10.16, indicating a potential upside of 55.31%. Given Tandem Diabetes Care's stronger consensus rating and higher probable upside, equities research analysts plainly believe Tandem Diabetes Care is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 0 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.53Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29 Which has more risk and volatility, TNDM or TMCI? Tandem Diabetes Care has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Does the media favor TNDM or TMCI? In the previous week, Treace Medical Concepts had 19 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 28 mentions for Treace Medical Concepts and 9 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 1.65 beat Treace Medical Concepts' score of 0.12 indicating that Tandem Diabetes Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Treace Medical Concepts 5 Very Positive mention(s) 4 Positive mention(s) 18 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better earnings and valuation, TNDM or TMCI? Treace Medical Concepts has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTandem Diabetes Care$982.95M1.53-$222.61M-$2.78-8.11Treace Medical Concepts$210.82M1.95-$49.53M-$0.85-7.69 Do insiders and institutionals hold more shares of TNDM or TMCI? 84.1% of Treace Medical Concepts shares are held by institutional investors. 1.9% of Tandem Diabetes Care shares are held by company insiders. Comparatively, 27.7% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community prefer TNDM or TMCI? Tandem Diabetes Care received 564 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 60.89% of users gave Tandem Diabetes Care an outperform vote while only 44.07% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformTandem Diabetes CareOutperform Votes59060.89% Underperform Votes37939.11% Treace Medical ConceptsOutperform Votes2644.07% Underperform Votes3355.93% SummaryTandem Diabetes Care beats Treace Medical Concepts on 11 of the 18 factors compared between the two stocks. Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$411.30M$4.53B$5.40B$8.49BDividend YieldN/A43.65%5.22%4.11%P/E Ratio-6.6129.8226.7119.93Price / Sales1.9570.77395.44119.84Price / CashN/A51.0838.2534.62Price / Book2.926.316.854.59Net Income-$49.53M$68.16M$3.23B$248.19M7 Day Performance-2.68%21.03%5.35%2.21%1 Month Performance1.55%25.54%13.31%16.23%1 Year Performance31.59%22.21%17.58%8.00% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts2.3204 of 5 stars$6.54-2.2%$10.16+55.3%+35.4%$411.30M$210.82M-6.61250Trending NewsTNDMTandem Diabetes Care4.5577 of 5 stars$23.45+2.0%$39.81+69.8%-50.2%$1.56B$982.95M-12.152,600Positive NewsCDRECadre2.7375 of 5 stars$35.75+1.0%$37.00+3.5%+12.0%$1.45B$559.81M43.072,240Gap UpEYENational Vision2.8017 of 5 stars$18.76+9.3%$17.57-6.3%+24.7%$1.36B$1.85B-93.8014,000Positive NewsAnalyst ForecastHigh Trading VolumeLQDALiquidia3.3913 of 5 stars$15.75+3.2%$27.13+72.2%+27.5%$1.35B$14.00M-9.6650News CoverageAnalyst DowngradeGap UpAORTArtivion1.618 of 5 stars$28.79-0.4%$31.40+9.1%+22.2%$1.23B$390.08M-1,439.351,300KMTSKestra Medical TechnologiesN/A$23.58+4.0%$27.50+16.6%N/A$1.21B$52.64M0.00300Positive NewsGap UpBLFSBioLife Solutions2.4747 of 5 stars$23.89+2.6%$31.17+30.5%+4.5%$1.13B$87.76M-22.54440News CoveragePositive NewsAnalyst DowngradeGap UpPLSEPulse Biosciences0.9005 of 5 stars$16.79-1.6%N/A+99.0%$1.13B$700,000.000.00140Gap UpFNAParagon 28N/A$13.11+0.1%$12.75-2.7%+75.0%$1.10B$256.18M-17.71343,000High Trading VolumeMDXGMiMedx Group3.9997 of 5 stars$7.25+2.8%$12.50+72.4%-10.4%$1.07B$352.38M13.18870Gap Up Related Companies and Tools Related Companies Tandem Diabetes Care Alternatives Cadre Alternatives National Vision Alternatives Liquidia Alternatives Artivion Alternatives Kestra Medical Technologies Alternatives BioLife Solutions Alternatives Pulse Biosciences Alternatives Paragon 28 Alternatives MiMedx Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMCI) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
